Equifax (NYSE:EFX) PT Raised to $129.00

Equifax (NYSE:EFX) had its target price boosted by Morgan Stanley from $115.00 to $129.00 in a report published on Friday, BenzingaRatingsTable reports. The firm currently has an equal weight rating on the credit services provider’s stock.

Several other brokerages have also recently issued reports on EFX. Barclays boosted their price objective on shares of WEX from $222.00 to $238.00 and gave the company an overweight rating in a research note on Monday, May 6th. ValuEngine cut shares of Zynerba Pharmaceuticals from a buy rating to a hold rating in a research note on Tuesday, May 28th. Royal Bank of Canada set a $184.00 price target on shares of Jazz Pharmaceuticals and gave the stock a buy rating in a research note on Wednesday, July 3rd. Deutsche Bank reaffirmed a hold rating on shares of United Parcel Service in a research note on Tuesday, July 2nd. Finally, Zacks Investment Research cut shares of HEXO from a hold rating to a sell rating in a research note on Wednesday, May 15th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and eight have assigned a buy rating to the stock. Equifax presently has an average rating of Hold and an average target price of $126.00.

Shares of EFX opened at $137.84 on Friday. The company has a quick ratio of 0.57, a current ratio of 0.57 and a debt-to-equity ratio of 1.02. The firm has a market cap of $16.59 billion, a PE ratio of 23.81, a P/E/G ratio of 2.85 and a beta of 1.24. The firm has a fifty day moving average price of $134.10. Equifax has a 1 year low of $88.68 and a 1 year high of $140.52.



Equifax (NYSE:EFX) last announced its quarterly earnings data on Friday, May 10th. The credit services provider reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.01. The company had revenue of $846.10 million for the quarter, compared to analysts’ expectations of $850.07 million. Equifax had a negative net margin of 10.23% and a positive return on equity of 21.95%. Equifax’s revenue was down 2.3% compared to the same quarter last year. During the same period in the previous year, the company posted $1.43 EPS. On average, sell-side analysts anticipate that Equifax will post 5.63 EPS for the current fiscal year.

Large investors have recently added to or reduced their stakes in the business. NuWave Investment Management LLC lifted its holdings in Equifax by 933.3% in the 2nd quarter. NuWave Investment Management LLC now owns 186 shares of the credit services provider’s stock valued at $25,000 after purchasing an additional 168 shares in the last quarter. Ellis Investment Partners LLC purchased a new position in Equifax in the 1st quarter valued at about $36,000. Parallel Advisors LLC lifted its holdings in Equifax by 139.0% in the 1st quarter. Parallel Advisors LLC now owns 380 shares of the credit services provider’s stock valued at $45,000 after purchasing an additional 221 shares in the last quarter. Trustcore Financial Services LLC purchased a new position in Equifax in the 1st quarter valued at about $54,000. Finally, Quadrant Capital Group LLC lifted its holdings in Equifax by 944.6% in the 1st quarter. Quadrant Capital Group LLC now owns 585 shares of the credit services provider’s stock valued at $67,000 after purchasing an additional 529 shares in the last quarter. Institutional investors own 94.43% of the company’s stock.

Equifax Company Profile

Equifax Inc provides information solutions and human resources business process outsourcing services for businesses, governments, and consumers. The company operates through four segments: U.S. Information Solutions (USIS), International, Workforce Solutions, and Global Consumer Solutions. The USIS segment offers consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting; mortgage loan origination information; financial marketing; and identity management services.

Featured Story: Compound Interest and Why It Matters When Investing

Analyst Recommendations for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.